Immunogenicity and Protective Capacity of a Virosomal Respiratory Syncytial Virus Vaccine Adjuvanted with Monophosphoryl Lipid A in Mice
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunogenicity and Protective Capacity of a Virosomal Respiratory Syncytial Virus Vaccine Adjuvanted with Monophosphoryl Lipid A in Mice
Authors
Keywords
-
Journal
PLoS One
Volume 7, Issue 5, Pages e36812
Publisher
Public Library of Science (PLoS)
Online
2012-05-10
DOI
10.1371/journal.pone.0036812
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis
- (2011) Jessie R. Groothuis et al. ADVANCES IN THERAPY
- Cost-effectiveness of Respiratory Syncytial Virus Prophylaxis in Various Indications
- (2011) Christian Hampp et al. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE
- Role of AS04 in human papillomavirus vaccine: mode of action and clinical profile
- (2011) Nathalie Garçon et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- The safety evaluation of adjuvants during vaccine development: The AS04 experience
- (2011) Nathalie Garçon et al. VACCINE
- Use of defined TLR ligands as adjuvants within human vaccines
- (2010) Malcolm S. Duthie et al. IMMUNOLOGICAL REVIEWS
- Biological challenges and technological opportunities for respiratory syncytial virus vaccine development
- (2010) Barney S. Graham IMMUNOLOGICAL REVIEWS
- Type I IFN enhances follicular B cell contribution to the T cell–independent antibody response
- (2010) Cristina L. Swanson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis
- (2010) Harish Nair et al. LANCET
- Pharmaceutical sciences in 2020
- (2010) Daan Crommelin et al. NATURE REVIEWS DRUG DISCOVERY
- Structural basis of respiratory syncytial virus neutralization by motavizumab
- (2010) Jason S McLellan et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The role of membrane fusion activity of a whole inactivated influenza virus vaccine in (re)activation of influenza-specific cytotoxic T lymphocytes
- (2010) Natalija Budimir et al. VACCINE
- Lipopeptide-adjuvanted respiratory syncytial virus virosomes: A safe and immunogenic non-replicating vaccine formulation
- (2010) Toon Stegmann et al. VACCINE
- AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
- (2009) A. M. Didierlaurent et al. JOURNAL OF IMMUNOLOGY
- Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant
- (2008) C. R. Casella et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease
- (2008) Maria Florencia Delgado et al. NATURE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search